The latest closing stock price for Aquestive Therapeutics as of May 28, 2025 is 2.73.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-830 today, roughly -1 times their original investment - a -22.36% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 5.80, which is 112.5% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.12, which is 22.3% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.57.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-830 today, roughly -1 times their original investment - a -22.36% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 5.80, which is 112.5% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.12, which is 22.3% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.57.